当前位置:首页 - 行情中心 - 泰林生物(300813) - 财务分析

泰林生物

(300813)

  

流通市值:12.67亿  总市值:23.28亿
流通股本:6144.00万   总股本:1.13亿

泰林生物(300813)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.11亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益65560.46万元,未分配利润24897.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产96208.91万元,负债30648.44万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入242,467,278.88156,282,129.7480,006,616.11269,856,059.81
营业总成本236,221,850.45151,988,460.4977,318,177.9264,005,837.7
营业利润12,850,755.647,454,530.25,839,769.8321,778,534.69
利润总额12,595,272.157,208,892.545,915,782.0721,975,925.39
净利润10,599,894.145,866,178.645,541,204.9118,445,191.48
其他综合收益----
综合收益总额10,599,894.145,866,178.645,541,204.9118,445,191.48
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计636,321,857.58617,406,145.54610,612,858.58638,750,200.42
非流动资产合计325,767,216.59332,239,323.03333,268,262.04334,757,707.45
资产总计962,089,074.17949,645,468.57943,881,120.62973,507,907.87
流动负债合计141,271,713.73135,565,439.86123,362,990.35161,808,999.1
非流动负债合计165,212,719.95163,250,484.8164,682,730.02161,459,731.44
负债合计306,484,433.68298,815,924.66288,045,720.37323,268,730.54
归属于母公司股东权益合计654,843,177.53650,069,174.73654,691,034.97648,762,936.31
股东权益合计655,604,640.49650,829,543.91655,835,400.25650,239,177.33
负债和股东权益合计962,089,074.17949,645,468.57943,881,120.62973,507,907.87
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计233,795,795.59148,599,488.0580,315,376.79348,325,147.14
经营活动现金流出小计254,510,790.13175,671,155.7986,611,769.63346,393,262.63
经营活动产生的现金流量净额-20,714,994.54-27,071,667.74-6,296,392.841,931,884.51
投资活动现金流入小计569,235,804.24377,891,894.5176,994,526.02397,897,984.8
投资活动现金流出小计540,813,362.92389,660,626.93176,608,235.15570,241,637.56
投资活动产生的现金流量净额28,422,441.32-11,768,732.43386,290.87-172,343,652.76
筹资活动现金流入小计15,645,426.78,250,155.45076,588,926.92
筹资活动现金流出小计10,920,399.2910,913,522.2090,171,511.17
筹资活动产生的现金流量净额4,725,027.41-2,663,366.750-13,582,584.25
汇率变动对现金及现金等价物的影响-151,083.968,903.7716,869.98301,016.42
现金及现金等价物净增加额12,281,390.29-41,434,863.15-5,893,231.99-183,693,336.08
期末现金及现金等价物余额110,182,347.0556,494,649.1992,036,280.3597,929,512.34
TOP↑